Neurol. praxi. 2024;25(6):455-464 | DOI: 10.36290/neu.2024.087

Management of patient with post-stroke cognitive impairment

MUDr. Dominik Koreň, PhD., Mgr. Miriam Slavkovská, PhD., prof. MUDr. Zuzana Gdovinová, PhD., FESO, FEAN
Neurologická klinika UPJŠ LF a UNLP Košice

Cognitive impairment (CI) after stroke is a frequent phenomenon. In some patients, CI can persist for a long time after overcoming stroke, which is referred to in the English literature as PCSI - post stroke cognitive impairment. It is a special nosological entity that needs to be diagnosed already during hospitalization, but a definitive diagnosis can only be made subsequently by a control examination of cognitive functions six months after stroke. The following article provides an up-to-date overview of the diagnosis, prediction and therapy of PSCI as a special nosological unit.

Keywords: post-stroke cognitive impairment, stroke, diagnostics, treatment.

Published: December 31, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koreň D, Slavkovská M, Gdovinová Z. Management of patient with post-stroke cognitive impairment. Neurol. praxi. 2024;25(6):455-464. doi: 10.36290/neu.2024.087.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 31.12.2025

    References

    1. Aggleton JP, O'Mara SM. The anterior thalamic nuclei: core components of a tripartite episodic memory system. Nature reviews. Neuroscience. 2022;23(8):505-516. Go to original source... Go to PubMed...
    2. Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019;322(16):1589-1599. Go to original source... Go to PubMed...
    3. Bach-Faig A, Berry EM, Lairon D, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14:2274-2284. Go to original source... Go to PubMed...
    4. Baker LD, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71-9. Go to original source... Go to PubMed...
    5. Barbay M, et al. Systematic Review and Meta-Analysis of Prevalence in Post-Stroke Neurocognitive Disorders in Hospital-Based Studies. Dementia and geriatric cognitive disorders. 2018;46(5-6):322-334. Go to original source... Go to PubMed...
    6. Bartoš A. Inovativní a původní české kognitivní testy Amnesia Light and Brief Assessment a Pojmenování obrázků a jejich vybavení a vyšetřovací metody v diagnostice kognitivních poruch a demencí. Med. praxi. 2022;19(1):50-57. Go to original source...
    7. Bayles MP, Swank AM, eds. [American College of Sports Medicine]. ACSM Guidelines for Exercise Testing and Prescription. Wolters Kluwer. 2018. ISBN 13:978-1-4963-3907-2.
    8. Beekly DL, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Disease and Associated Disorders. 2007;21(3):249-258. Go to original source... Go to PubMed...
    9. Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: The stroke recovery and rehabilitation roundtable taskforce. Neurorehabilitation and Neural Repair. 2017;31:793-799. Go to original source... Go to PubMed...
    10. Binder JR, Frost JA, Hammeke TA, e tal. Human brain language areas identified by functional magnetic resonance imaging. J Neurosci. 1997;17(1):353-62. Go to original source... Go to PubMed...
    11. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing. 1996;25:113-120. Go to original source... Go to PubMed...
    12. Cao Q, et al. The Prevalence of Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer's disease: JAD. 2020;73(3):1157-1166. Go to original source... Go to PubMed...
    13. Coen RF, et al. Strengths and Limitations of the MoCA for Assessing Cognitive Functioning: Findings From a Large Representative Sample of Irish Older Adults. Journal of geriatric psychiatry and neurology. 2016;29(1):18-24. Go to original source... Go to PubMed...
    14. Cui L, Hong H, Wang S, et al. Small vessel disease and cognitive reserve oppositely modulate global network redundancy and cognitive function: A study in middle-to-old aged community participants. Hum Brain Mapp. 2024;45(5):e26634. Go to original source... Go to PubMed...
    15. Custodio N, Montesinos R, Lira D, et al. Mixed dementia: A review of the evidence. Dement Neuropsychol. 2017;11(4): 364-370. Go to original source... Go to PubMed...
    16. Davis C, et al. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015;7(11):9139-53. Go to original source... Go to PubMed...
    17. Demeyere N. Acute post-stroke screening for a cognitive care pathway. The lancet. Healthy longevity. 2024;5(1):e4-e5. Go to original source... Go to PubMed...
    18. Dhakal A, Bobrin BD. Cognitive Deficits. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022.
    19. Diagnostické štandardy MZSR. Dostupné na: https://www.health.gov.sk/Zdroje?/Sources/dokumenty/ SDTP/standardy/Nove/Psychiatria-Demencia_pri_Alzheimerovej_chorobe.pdf.
    20. Dong Y, Ding M, Cui M, et al. Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months. Aging (Albany NY). 202;13(17):21628-21641. Go to original source... Go to PubMed...
    21. Douiri A, et al. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010. Stroke. 2013;44,(1):138-45.
    22. Erickson KI, Hillman C, Stillman CM, et al. Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines. 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*. Med Sci Sports Exerc. 2019;51(6):1242-1251. Go to original source... Go to PubMed...
    23. Evans MDR, Kelley P, Kelley J. Identifying the Best Times for Cognitive Functioning Using New Methods: Matching University Times to Undergraduate Chronotypes. Front Hum Neurosci. 2017;11:188. Go to original source... Go to PubMed...
    24. Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2022;47(1):72-89. Go to original source... Go to PubMed...
    25. García-Alberca JM, Mendoza S, Gris E. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia. Clin Drug Investig. 2022;42(5):391-402. Go to original source... Go to PubMed...
    26. Gauthier L, Gelinas I, Mcintyre M, et al. Disability Assessment for Dementia (DAD) user's guide. 1994.
    27. Gauthier S, Gelinas I, Gauthier L. Functional disability in Alzheimer's disease. Int Psychogeriatr. 1997;9(Suppl 1):163-165. Go to original source... Go to PubMed...
    28. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. Go to original source... Go to PubMed...
    29. Godefroy O, Yaïche H, Taillia H, et al., and GRECogVASC Study Group. Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score. Neurology. 2018; 91:e1979-87. Go to original source... Go to PubMed...
    30. Heiss WD, Rosenberg GA, Thiel A, et al. Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Med. 2016;14(1):174. Go to original source... Go to PubMed...
    31. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9(Suppl 2):20-26. Go to original source... Go to PubMed...
    32. Chander, Russell J, et al. Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke. Scientific reports. 2017;7(1):12441. Go to original source... Go to PubMed...
    33. Chaves MLF, Godinho CC, Porto CS, et al.; Group Recommendations in Alzheimer's Disease and Vascular Dementia of the Brazilian Academy of Neurology. Cognitive, functional and behavioral assessment: Alzheimer's disease. Dement Neuropsychol. 2011;5(3):153-166. Go to original source... Go to PubMed...
    34. Chippa V, Roy K. Geriatric Cognitive Decline and Polypharmacy. StatPearls. StatPearls Publishing. 2023.
    35. Chiti G, Pantoni L. Use of Montreal Cognitive Assessment in patients with stroke. Stroke. 2014;45(10):3135-40. Go to original source... Go to PubMed...
    36. Iadecola C, Duering M, Hachinski V, et al. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(25):3326-3344. Go to original source... Go to PubMed...
    37. Jaroenngarmsamer T, Benali F, Fladt J, et al; ESCAPE-NA1 Investigators. Cortical and Subcortical Brain Atrophy Assessment Using Simple Measures on NCCT Compared with MRI in Acute Stroke. AJNR Am J Neuroradiol. 2023. Go to original source... Go to PubMed...
    38. Jokinen H, Kalska H, Mäntylä R, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry. 2006;77(1):28-33. Go to original source... Go to PubMed...
    39. Jorm AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med. 1991;21:785-90. Go to original source... Go to PubMed...
    40. Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862:915-925. Go to original source... Go to PubMed...
    41. Kandiah N, Chander RJ, Lin X, et al. Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score. J Alzheimers Dis. 2016;49:1169-77. Go to original source... Go to PubMed...
    42. Kandiah N, Ong PA, Yuda T, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. CNS Neurosci Ther. 2019;25(2):288-298. Go to original source... Go to PubMed...
    43. Kaushik S, Vani K, Chumber S, et al. Evaluation of MR Visual Rating Scales in Major Forms of Dementia. J Neurosci Rural Pract. 2021;12(1):16-23. doi: 10.1055/s-0040-1716806. Go to original source... Go to PubMed...
    44. Kim JO, Lee SJ, Pyo JS. Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: a meta-analysis. PLoS One. 2020;15(2):e0227820. Go to original source... Go to PubMed...
    45. Kristensson JH, et al. Medications causing potential cognitive impairment are common in nursing home dementia units - a cross-sectional study. Exploratory research in clinical and social pharmacy. 2021;3:100054. Go to original source... Go to PubMed...
    46. Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76:914-922. Go to original source... Go to PubMed...
    47. Lee HB, DeLoatch CJ, Cho S, et al. Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit. Crit Care Clin. 2008;24(4):723-36. Go to original source... Go to PubMed...
    48. Lee JH, Kim SH, Kim GH, et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology. 2011;77(1):18-25. Go to original source... Go to PubMed...
    49. Li J, Wang J, Wu B, et al. Association Between Early Cognitive Impairment and Midterm Functional Outcomes Among Chinese Acute Ischemic Stroke Patients: A Longitudinal Study. Front Neurol. 2020;11:20. Go to original source... Go to PubMed...
    50. Lim JS, Lee JJ, Woo CW. Post-Stroke Cognitive Impairment: Pathophysiological Insights into Brain Disconnectome from Advanced Neuroimaging Analysis Techniques. J Stroke. 2021;23(3):297-311. Go to original source... Go to PubMed...
    51. Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke. 2009;40:S2-S3. Go to original source... Go to PubMed...
    52. Lo JW, et al. Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups. Neurology. 2019;93(24):e2257-e2271. Go to original source... Go to PubMed...
    53. Mahoney Fl, Barthel DW Functional evaluation: the Barthel index. Md State Med J. 1965;14:61- 65. Go to original source...
    54. Makin SD, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry. 2013;84(8):893-900. Go to original source... Go to PubMed...
    55. Malleta GJ. The concept of reversible dementia. How nonreliable terminology may impair effective treatment. J Am Geriatr Soc. 1990;38:136-140. Go to original source... Go to PubMed...
    56. Mendonça MD, Alves L, Bugalho P. From Subjective Cognitive Complaints to Dementia Who is at Risk?: A Systematic Review. Am J Alzheimers Dis Other Demen. 2016;31(2):105-114. Go to original source... Go to PubMed...
    57. Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695-9. Go to original source... Go to PubMed...
    58. Nys GMS, van Zandvoort MJE, de Kort PLM, et al. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis. 2007;23(5-6):408-16. Go to original source... Go to PubMed...
    59. O'Sullivan MJ, et al. Cognitive Recovery After Stroke: Memory. Stroke. 2023;54(1):44-54. Go to original source... Go to PubMed...
    60. Pais R, Ruano LP, Carvalho O, Barros H. Global Cognitive Impairment Prevalence and Incidence in Community Dwelling Older Adults-A Systematic Review. Geriatrics (Basel). 2020;5(4):84. Go to original source... Go to PubMed...
    61. Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016;22(2 Dementia):404-418. Go to original source... Go to PubMed...
    62. Petersen SE, Sporns O. Brain Networks and Cognitive Architectures. Neuron. 2015;88(1):207-19. Go to original source... Go to PubMed...
    63. Powers WJ, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. Go to original source... Go to PubMed...
    64. Preventívne postupy MZSR. Dostupné na: https://www.standardnepostupy.sk/novy-zoznam-schvalenych-preventivnych-postupov-ppvp/.
    65. Quinn TJ, et al. European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. European journal of neurology. 2021;28(12):3883-3920. Go to original source... Go to PubMed...
    66. Rost NS, Brodtmann A, Pase MP, et al. Post-Stroke Cognitive Impairment and Dementia. Circ Res. 2022;130(8):1252-1271. Go to original source... Go to PubMed...
    67. Sachdev PS, Brodaty H, Valenzuela MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-283. Go to original source... Go to PubMed...
    68. Salvadori E, Cova I, Mele F, et al. Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets. Aging Clin Exp Res. 2022;34(8):1855-1863. Go to original source... Go to PubMed...
    69. Salvadori E, Pasi M, Poggesi A, et al. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol. 2013;260(9):2220-7. Go to original source... Go to PubMed...
    70. Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4:160-71. Go to original source... Go to PubMed...
    71. Sharma R, Mallick D, Llinas RH, Marsh EB. Early Post-stroke Cognition: In-hospital Predictors and the Association With Functional Outcome. Front Neurol. 2020;11:613607. Go to original source... Go to PubMed...
    72. Schellekens MM, et al. Subacute cognitive impairment after first-ever transient ischemic attack or ischemic stroke in young adults: The ODYSSEY study. European stroke journal. 2023;8(1):283-293. Go to original source... Go to PubMed...
    73. Silhan D, Pashkovska O, Bartos A; Alzheimer's Disease Neuroimaging Initiative. Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease. J Alzheimers Dis. 2021;84(3):1259-1266. Go to original source... Go to PubMed...
    74. Skrobot OA, et al. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2017;13(6):624-633. Go to original source... Go to PubMed...
    75. Sulter G, Steen C, De KJ. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30:1538-1541. Go to original source... Go to PubMed...
    76. Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19:771-783. Go to original source... Go to PubMed...
    77. Teng E, Becker BW, Woo E, et al. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24(4):348-53. Go to original source... Go to PubMed...
    78. Thiebaut de Schotten M, et al. Brain disconnections link structural connectivity with function and behaviour. Nature communications. 2020;11(1):5094. Go to original source... Go to PubMed...
    79. Vakil E. Neuropsychological assessment: principles, rationale, and challenges. Journal of clinical and experimental neuropsychology. 2021;34(2):135-50. Go to original source... Go to PubMed...
    80. van de Pol LA, Hensel A, Barkhof F, et al. Hippocampal atrophy in Alzheimer disease: age matters. Neurology. 2006;66(2):236-238. Go to original source... Go to PubMed...
    81. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van GJ. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607. Go to original source... Go to PubMed...
    82. Weaver NA, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. The Lancet. Neurology. 2021;20(6):448-459. Go to original source... Go to PubMed...
    83. Weintraub S, Wicklund AH, Salmon DP. The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(4):a006171. Go to original source... Go to PubMed...
    84. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147(9):1561-1564. Go to original source...
    85. Zach P, Bartoš A, Lagutina A, et al. Easy Identification of Optimal Coronal Slice on Brain Magnetic Resonance Imaging to Measure Hippocampal Area in Alzheimer's Disease Patients. Biomed Res Int. 2020;2020:5894021. Go to original source... Go to PubMed...
    86. Zhan M, Sun L, Liu J, et al. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis. Oxid Med Cell Longev. 2021;2021:878768. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.